THE TWO-WAY STREET BETWEEN PERIODONTAL DISEASES AND DIABETES


The Two-way Street between Periodontal Diseases and Diabetes


Renata Cimões1, Roberto Carlos Mourão Pinho2

1Associate Professor of the Department of Prosthesis and Buco-Facial Surgery at UFPE; Post-Doctorate in Periodontics Eastman Dental Institute, London. PhD in Dentistry; Specialist in Periodontics; ITI Fellow, Speaker and Study Club Director; 2Post-Doctorate in Dentistry UFPE; PhD in Dentistry UFPE; Specialist in Dentistry for Patients with Special Needs; Specialist in Endodontics; Molecular Biology Specialist


Periodontitis is a chronic inflammatory disease that is initiated by the accumulation of dental biofilm, where dysbiosis leads to a chronic non-resolving condition, and destructive inflammatory response. The destruction of tissues that we clinically recognize as periodontitis (that is, destruction of the periodontal ligament, periodontal pocket formation and alveolar bone resorption) is caused mainly by the host’s inflammatory response to the bacterial challenge presented by the biofilm [38].
Periodontitis affects, in its severe forms, approximately 10% of the global population, which represents almost 750 million people worldwide[16]. The prevalence of periodontitis among all adults aged 30 years and over registered by the National Health and Nutrition Examination Survey (NHANES) in the United States is 46% [8]. In addition, periodontitis has been found to be more severe and 3 times more likely to occur in patients with diabetes mellitus (DM) compared to the general population [14,25], and the level of glycemic control is the key to determining risk, and similar to other diabetes complications, the risk of periodontitis increases with a worse glycemic index [33].
DM, a chronic non-communicable metabolic disease, occurs when blood glucose levels are increased, or because the body cannot produce any, or enough insulin, or use insulin effectively [15].


Keywords: Periodontal Diseases; Diabetes

Free Full-text PDF


How to cite this article:
Renata Cimões, Roberto Carlos Mourão Pinho. The Two-way Street between Periodontal Diseases and Diabetes. International Research Journal of Diabetes and Metabolism, 2021, 4:18. DOI: 10.28933/irjdm-2021-08-1006


References

1. AKAZAWA, H. Periodontitis and Diabetes Mellitus: Be true to your teeth. Int Heart J, vol. 59, n. 4, 2018, p. 680-682. doi:10.1536/ihj.18-410.
2. APATZIDOU, D.A.; RIGGIO, M.P.; KINANE, D.F. Quadrant root planing versus same-day full-mouth root planing. II. Microbiological findings. J Clin Periodontol, vol. 31, n. 2, 2004, p. 141-148. doi:10.1111/j.0303-6979.2004.00462.x.
3. BORILOVA LINHARTOVA, P.; KAVRIKOVA, D.; TOMANDLOVA, M., et al. Differences in Interleukin-8 Plasma Levels between Diabetic Patients and Healthy Individuals Independently on Their Periodontal Status. Int J Mol Sci, vol. 19, n. 10, 2018, p. 3214. doi:10.3390/ijms19103214.
4. BROWN, L.J.; LÖE, H. Prevalence, extent, severity and progression of periodontal disease. Periodontol 2000, vol. 2, 1993, p. 57–71.
5. CDC Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services C for DC and P http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. (2011). National Diabetes Fact Sheet, 2011. Atlanta; 2011. Available from: http://www.cdc.gov/.
6. DEL TURCO, S.; BASTA, G. An update on advanced glycation endproducts and atherosclerosis. Biofactors, vol. 38, n. 4, 2012, p. 266-274. doi:10.1002/biof.1018.
7. DIAS, R.S.A.M.; PINHO, R.C.M.; ALMEIDA F.R.; CELERINO; R., CIMÕES; R., et al. Evaluation of DEFB1 polymorphisms in individuals with chronic periodontitis and diabetes mellitus type 2 in a population of northeastern Brazil. Special Care in Dentistry, vol. 38, n. 4, 2018, p. 227-233. doi:10.1111/scd.12296.
8. EKE, P.I.; DYE, B.A.; WEI, L.; SLADE, G.D.; THORNTON-EVANS, G.O.; BORGNAKKE, W.S.; et al. Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. J Periodontol, vol. 86, n. 5, 2015, p. 611–22. https://doi.org/10.1902/jop.2015.140520.
9. FARIA-ALMEIDA, R.; NAVARRO, A.; BASCONES, A. Clinical and metabolic changes after conventional treatment of type 2 diabetic patients with chronic periodontitis. J Periodontol, vol. 77, n. 4, 2006, p. 591-598. doi:10.1902/jop.2006.050084.
10. GENCO, R.J.; BORGNAKKE, W.S. Risk factors for periodontal disease. Periodontol 2000, vol 62, n. 1, 2013, p. 59–94.
11. GRAVES, D.T.; CORRÊA, J.D.; SILVA, T.A. The Oral Microbiota Is Modified by Systemic Diseases, vol. 98, n. 2, 2019, p. 148-156. doi:10.1177/0022034518805739.
12. HASHIOKA, S.; INOUE, K.; HAYASHIDA, M.; WAKE, R.; OH-NISHI, A. Implications of Systemic Inflammation and Periodontitis for Major Depression, vol. 12, July, 2018, p. 1–7.
13. IWASAKI, M.; KIMURA, Y.; OGAWA, H.; YAMAGA, T.; ANSAI, T.; WADA, T., et al. Periodontitis, periodontal inflammation, and mild cognitive impairment: A 5­year cohort study. Journal of Periodontal Research, 2019, 54(3), 233-240.
14. IZUORA, K.; YOUSIF, A.; ALLENBACK, G.; GEWELBER, C.; NEUBAUER, M. Relationship between dental loss and health outcomes among hospitalized patients with and without diabetes. Journal of Investigative Medicine, vol. 67, n. 3, 2019, p. 669-673.
15. KALAITZOGLOU, E.; FOWLKES, J.L.; POPESCU, I.; THRAILKILL, K.M. Diabetes pharmacotherapy and effects on the musculoskeletal system. Diabetes/metabolism research and reviews, vol. 35, n. 2, 2019, p. e3100.
16. KASSEBAUM, N. J.; BERNABÉ, E.; DAHIYA, M.; BHANDARI, B.; MURRAY, C. J. L.; MARCENES, W. Global burden of severe periodontitis in 1990– 2010: A systematic review and meta-regression. Journal of Dental Research, vol. 93, 2014, p. 1045–1053. https://doi.org/10.1177/0022034514552491.
17. KATZ, J.; BHATTACHARYYA, I.; FARKHONDEH-KISH, F.; PEREZ F.M.; CAUDLE R.M.; HEFT M.W. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol, vol. 32, n. 1, 2005, p. 40-44. doi:10.1111/j.1600-051X.2004.00623.x.
18. KOCHER, T.; KÖNIG, J.; SYLLING, W.; CHRISTIANE, B.; MEISEL, P.; KOCHER, T. Periodontal complications of hyperglycemia/diabetes mellitus: Epidemiologic complexity and clinical challenge. Periodontology 2000. 2018, p. 59–97.
19. KSIAZEK, K.; BLASZCZAK, J.; BURACZYNSKA, M. IL4 gene VNTR polymorphism in chronic periodontitis in end-stage renal disease patients. Oral Dis., vol. 25, n. 1, 2019, p. 258-264. doi:10.1111/odi.12974.
20. LIU, C.; FENG, X.; LI, Q.; WANG, Y.; LI, Q.; HUA, M. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis. Cytokine, vol. 86, 2016, pp. 100-109. doi:10.1016/j.cyto.2016.06.028.
21. LÖE, H. Periodontal Disease. The sixth complication of diabetes mellitus. Diabetes Care, vol. 16, n.1, 1993, p. 329-34.
22. LUCENA, K.; LIMA JUNIOR, S.; RIBEIRO, I.; CIMÕES, R.; CARVALHO, A. Clinical and Metabolic Effects of two Periodontal Therapeutic Modalities in Diabetic Patients with Residual Pockets. Pesqui Bras Odontopediatria Clin Integr, vol. 17, n. 1, 2017, p. e2577. http://dx.doi.org/10.4034/PBOCI.2017.171.02.
23. MAPANGA, R.F.; ESSOP, M.F. Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways. Am J Physiol Circ Physiol, v. 310, n. 2, 2016, p. H153–73.
24. MARINHO, M.C.; PACHECO, A.B.F.; COSTA, G.C.V.; ORTIZ, N.D.; ZAJDENVERG, L.; SANSONE C. Quantitative gingival crevicular fluid proteome in type 2 diabetes mellitus and chronic periodontitis. Oral Dis., vol. 25, n. 2, 2019, p. 588-595. doi:10.1111/odi.12996.
25. MEALEY, B.L.; OCAMPO, G.L. Diabetes mellitus and periodontal disease. Periodontol 2000, vol. 44, 2007, p. 127–153.
26. MEALEY, B.L.; OATES, T.W.; AMERICAN ACADEMY OF PERIODONTOLOGY. Diabetes mellitus and periodontal diseases. J Periodontol, vol. 77, n. 8), 2006, p. 1289-1303. doi:10.1902/jop.2006.050459.
27. NAIFF, P.; CARNEIRO, V.; GUIMARÃES, M. DO C. Importance of Mechanical Periodontal Therapy in Patients with Diabetes Type 2 and Periodontitis. Int J Dent, 2018, 2018, p.1–7.
28. NASSAR, H.; KANTARCI, A.; VAN DYKE, T.E. Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation. Periodontol 2000, vol. 43, 2007, p. 233-44. doi: 10.1111/j.1600-0757.2006.00168.x. PMID: 17214841; PMCID: PMC2034354.
29. PAGE, RC. The Pathobiology of Periodontal Diseases May Affect Systemic Diseases: Inversion of a Paradigm. Ann Periodontol, vol. 3, n. 1, 1998, 108–20.
30. PENG, C.H.; YANG, Y.S.; CHAN, K.C.; KORNELIUS, E.; CHIOU, J.Y.; HUANG, C.N. Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Intern Med, vol. 56, vol. 9, 2017, p. 1015-1021. doi:10.2169/internalmedicine.56.7322.
31. PHILLIPS, L.S.; RATNER, R.E.; BUSE, J.B.; KAHN, S.E. We can change the natural history of type 2 diabetes. Diabetes Care, vol. 37, n. 10, 2014, p. 2668–76.
32. PICKUP, J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, vol. 27, n. 3, 2004, p. 813-823. doi:10.2337/diacare.27.3.813.
33. PIHLSTROM B. L, MICHALOWICZ B. S, JOHNSON N. W. Periodontal diseases. Lancet 2005; 366: 1809–1820.
34. PINHO, R.C.M.; DIAS, R.S.A.M.; BANDEIRA, F., CIMÕES R. et al. Polymorphisms of the vitamin D receptor gene (FOKI, CDX2, and GATA) and susceptibility to chronic periodontitis in diabetic and non-diabetic individuals: A case-control study. J Investig Clin Dent, vol. 10, n. 1, 2019, p. e12370. doi:10.1111/jicd.12370.
35. PINHO, R.C.M.; DE MELO DIAS, R.S.A.; BANDEIRA, F.; DA SILVA BARBOSA, A. C.; JÚNIOR, A. D.F.C.; CIMÕES, R. Impact of Chronic Periodontitis on the Quality of Life of Individuals with and without Diabetes. Health Science Journal, vol. 12, n. 2, 2018, p. 1-11.
36. PINHO, R.C.M.; DIAS, R.S.A.M.; RODRIGUES, J.K.F.; DOS SANTOS, E.U.D.; LUNA, G.M.; CIMÕES, R. Single Nucleotide Polymorphism (Rs4804803) in the DC-SIGN Promoter Region Cd209 and Implications Regarding the Susceptibility to Chronic Periodontitis in Individuals with Type 2 Diabetes Mellitus. Health Sci J, vol. 12, n. 4, 2018, p. 580. DOI: 10.21767/1791-809X.1000580.
37. POLAK, D.; SHAPIRA, L. An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol, vol. 45, n. 2, 2018, p. 150-166. doi:10.1111/jcpe.12803.
38. PRESHAW, P.M.; BISSETT, S.M. Periodontitis and diabetes [J]. British dental journal, vol. 227, n. 7, 2019, p. 577-584. https://doi.org/10.1038/s41415-019-0794-5.
39. QUINTERO, A.J.; CHAPARRO, A.; QUIRYNEN, M., et al. Effect of two periodontal treatment modalities in patients with uncontrolled type 2 diabetes mellitus: A randomized clinical trial. J Clin Periodontol, vol. 45, n. 9, 2018, p. 1098-1106. doi:10.1111/jcpe.12991.
40. SABHARWAL, A.; GOMES-FILHO, I.S.; STELLRECHT, E.; SCANNAPIECO, F.A.. Role of periodontal therapy in management of common complex systemic diseases and conditions: An update. Periodontol 2000, vol. 78, n. 1, 2018, p. 212-226. doi:10.1111/prd.12226.
41. SANTOS, V.R.; LIMA, J.A.; DE MENDONÇA, A.C.; BRAZ MAXIMO, M.B.; FAVERI, M.; DUARTE P.M. Effectiveness of full-mouth and partial-mouth scaling and root planing in treating chronic periodontitis in subjects with type 2 diabetes. J Periodontol, vol. 80, n. 8, 2009, p.1237-1245. doi:10.1902/jop.2009.090030.
42. SPRANGER, J.; KROKE, A.; MÖHLIG, M., et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes, 52, n. 3, 2003, p. 812-817. doi:10.2337/diabetes.52.3.812.
43. TEEUW, W.J.; GERDES, V.E.; LOOS, B.G. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care, vol. 33, n. 2, 2010, p. 421-427. doi:10.2337/dc09-1378.
44. TUNES, R.S.; FOSS-FREITAS, M.C.; NOGUEIRA-FILHO, G.D.R. Impact of periodontitis on the diabetes-related inflammatory status. J Can Dent Assoc, vol. 76, n. 35, 2010, p. 1-7.


Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details).



This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.